Emerging treatment options for short bowel syndrome: potential role of teduglutide

INTRODUCTION: Current medical management of short bowel syndrome (SBS) involves the use of lifelong parenteral nutrition (PN). Glucagon-like peptide-2 (GLP-2), an important intestinotrophic growth factor has been shown to increase intestinal absorption in SBS through augmentation of post-resection i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tee, Cheng T, Wallis, Katharina, Gabe, Simon M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3190286/
https://www.ncbi.nlm.nih.gov/pubmed/22016579
http://dx.doi.org/10.2147/CEG.S13906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3190286/
https://www.ncbi.nlm.nih.gov/pubmed/22016579
http://dx.doi.org/10.2147/CEG.S13906

Ejemplares similares